ScholarIQanswers from OpenAlex

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

PaperCitations, authors & open-access status

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder have?

ScholarIQcitation count

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder has 138 citations in the OpenAlex counts ScholarIQ stores.

When was Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder published?

ScholarIQyear

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder has 1998 year in the ScholarIQ index.

What is the open-access status of Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder?

ScholarIQoa status

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder has closed oa status in the ScholarIQ index.

What is the DOI of Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder?

ScholarIQdoi

The DOI for Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder is on the source record.

What is the PMID of Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder?

ScholarIQpmid

The PMID for Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder is on the source record.

What is the OpenAlex record for Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder?

ScholarIQopenalex

The OpenAlex for Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial